We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

87 hedge funds and large institutions have $190M invested in Antares Pharma, Inc. in 2013 Q2 according to their latest regulatory filings, with 87 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

70% less call options, than puts

Call options by funds: $650K | Put options by funds: $2.17M

Holders
87
Holders Change
+87
Holders Change %
–
% of All Funds
2.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
87
Increased
–
Reduced
–
Closed
–
Calls
$650K
Puts
$2.17M
Net Calls
-$1.52M
Net Calls Change
-$1.52M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$817K +$759K +196,437 New
B
27
Baird
Wisconsin
$765K +$711K +184,000 New
TA
28
Teachers Advisors
New York
$615K +$571K +147,917 New
Wells Fargo
29
Wells Fargo
California
$547K +$508K +131,500 New
SIC
30
Salem Investment Counselors
North Carolina
$545K +$506K +131,120 New
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$514K +$477K +123,501 New
BP
32
Ballentine Partners
Massachusetts
$499K +$464K +120,000 New
NPC
33
National Planning Corporation
California
$499K +$469K +121,450 New
Swiss National Bank
34
Swiss National Bank
Switzerland
$496K +$461K +119,300 New
Group One Trading
35
Group One Trading
Illinois
$446K +$414K +107,219 New
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$424K +$393K +101,862 New
Citigroup
37
Citigroup
New York
$406K +$376K +97,407 New
Deutsche Bank
38
Deutsche Bank
Germany
$402K +$374K +96,893 New
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$401K +$372K +96,413 New
AQR Capital Management
40
AQR Capital Management
Connecticut
$390K +$362K +93,631 New
VOYA Investment Management
41
VOYA Investment Management
Georgia
$389K +$362K +93,600 New
MLICM
42
Metropolitan Life Insurance Company (MetLife)
New York
$382K +$355K +91,915 New
NFA
43
Nationwide Fund Advisors
Ohio
$344K +$320K +82,789 New
AIG
44
American International Group
New York
$306K +$285K +73,665 New
State Board of Administration of Florida Retirement System
45
State Board of Administration of Florida Retirement System
Florida
$306K +$284K +73,444 New
ProShare Advisors
46
ProShare Advisors
Maryland
$290K +$269K +69,629 New
Goldman Sachs
47
Goldman Sachs
New York
$288K +$268K +69,277 New
BA
48
BlackRock Advisors
Delaware
$288K +$268K +69,289 New
Citadel Advisors
49
Citadel Advisors
Florida
$240K +$223K +57,628 New
U
50
UBS
Switzerland
$232K +$216K +55,837 New
1
2
3 4

ATRS Hedge Fund Activity: Q2 2013 in Review

87 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q2 2013, worth a combined $190M.

Buyers outnumbered sellers: 87 funds opened new ATRS positions and 0 closed out — a net gain of 87 holders — while 0 added to existing stakes and 0 trimmed.

  • 87 institutional investors held Antares Pharma, Inc. (ATRS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $190M of Antares Pharma, Inc. stock for Q2 2013.
  • 87 funds opened new Antares Pharma, Inc. positions in Q2 2013 and 0 closed out, a net change of +87 holders.

Based on aggregated 13F filings for Q2 2013.